hero section gradient
17 handpicked stocks

Companies That Give Back

Channel your investments toward companies that make philanthropy a priority. These stocks have been carefully selected by our analysts for their commitment to giving back while building sustainable businesses that could deliver long-term value to investors.

Author avatar

Han Tan | Market Analyst

Published on June 17

Your Basket's Financial Footprint

Summary of total market capitalisation and investor takeaways for the provided stock basket.

Key Takeaways for Investors:
  • Large-cap dominance tends to reduce volatility and produce performance closer to broad-market returns.
  • Best employed as a core, long-term holding within a diversified portfolio, not as a speculative trade.
  • Likely to deliver steady, long-term value rather than rapid, short-term gains.
Total Market Cap
  • MSFT: $3.85T

  • CRM: $250.77B

  • GOOGL: $3.03T

  • Other

About This Group of Stocks

1

Our Expert Thinking

Companies that prioritize giving back often build stronger brands and more sustainable business models. These firms demonstrate their values through significant charitable giving and community programs, potentially positioning them for loyal customers and long-term stability.

2

What You Need to Know

This collection spans diverse sectors including technology, healthcare, retail, and consumer goods. Each company has earned recognition for their philanthropic initiatives, from product donations to community development. Their social responsibility may signal good governance and sustainable business practices.

3

Why These Stocks

These companies weren't selected randomly—they've demonstrated consistent commitment to philanthropy through foundations, financial contributions, and volunteering programs. With growing investor interest in ESG factors, these firms may be well-positioned as values-based investing continues to gain momentum.

Why You'll Want to Watch These Stocks

💖

Do Well While Doing Good

These companies aren't just writing checks—they've built giving into their business models. As consumers increasingly support brands that share their values, these firms may have an edge in building customer loyalty.

📈

The ESG Momentum

ESG investing is gaining serious traction. With more investors looking for socially responsible companies, these philanthropic leaders could experience increased demand and potentially attractive valuations.

🔮

Tomorrow's Business Leaders

Companies that focus on community impact often attract and retain top talent while building more resilient business models. Their long-term perspective might translate to sustainable growth that outlasts market cycles.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions